|Bid||1.6500 x 0|
|Ask||1.6800 x 0|
|Day's Range||1.6000 - 1.6900|
|52 Week Range||1.4800 - 6.8500|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 20, 2019 - Feb 25, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||7.00|
Canadian cannabis company Zenabis Global Inc. said Tuesday it has received a licence to add 9,900 kg of licensed annual cultivation capacity at its Zenabis Langley facility. Vancouver-based Zenabis said the move increases its total licensed annual cultivation capacity to 42,800 kg of dried cannabis from 32,900 kg, an increase of more than 30%. The company has now received licenses for all four its facilities with 438,200 sq. feet of licensed operational space. U.S.-listed shares were not yet active premarket, but have fallen 19% in the last three months, while the S&P 500 has fallen 3%.
Shares of Canadian cannabis company Zenabis Global Inc. rose about 3% Monday, after the company said Health Canada has approved the license for an additional 9.8 tons of production capacity. The move brings the company's total capacity to 32.9 tonnes, up more than 40%. GMP analyst Justin Keywood said the news is consistent with his expected timing. The company is expecting annual licensed capacity to increase to 131.2 tons by the third quarter. If that materializes, it would position the company as a top 5 producer among Canadian licensed players. "In our view, the continued licensing progress for ZENA's facilities helps de-risk our near-term forecasts," said Keywood. The stock is trading well below peers at 6.5 times 2020 EBITDA, while rivals trade at an average of about 20 times, he wrote. GMP rates the stock a buy with a stock price target of C$3.25 ($2.47) that's more than double its current level.
Zenabis Global Inc. did the unlikely Tuesday: The cannabis company raised cash without going to a group of hedge funds in Canada that deploy aggressive trading strategies to recycle capital in the pot industry.
Cannabis stocks rose Thursday, led by Aleafia Health Inc., which rallied after announcing the closure of a $40. 25 million convertible debt offering that will bolster its balance sheet and help grow its business.
VANCOUVER , May 24, 2019 /CNW/ - Zenabis Global Inc. (ZENA.V) ("Zenabis" or the "Company") is pleased to announce that it has received final approval for the listing of the Company's common shares ("Common Shares") and outstanding listed common share purchase warrants ("Warrants") on the Toronto Stock Exchange (the "TSX"). The Company's Common Shares and Warrants will begin trading on the TSX effective as of market open on May 27, 2019 .
VANCOUVER , May 21, 2019 /CNW/ - Zenabis Global Inc. (ZENA.V) ("Zenabis" or the "Company") today announced the appointment of Natascha Kiernan , an experienced international finance and M&A attorney who has held senior positions at several prominent international law firms, as the newest member of its Board of Directors, effective May 20, 2019 . Ms. Kiernan's experience includes working as Counsel in the London office of Skadden, Arps, Slate, Meagher & Flom LLP and she has represented Fortune 500 companies, financial institutions and international governments in complex corporate finance and M&A transactions totalling more than $100 billion in value and spanning six continents. Ms. Kiernan holds a J.D. from Columbia University School of Law and is qualified to practice law in New York and England & Wales .
Construction and licensing continue to progress on track at Zenabis Atholville and Zenabis Langley, with annual design capacity forecast to increase to at least 131,300 kg in the third quarter of 2019. Zenabis has consistently grown more than the previous month's harvest weight from October 2018 to April of 2019.
VANCOUVER , May 13, 2019 /CNW/ - Zenabis Global Inc. (ZENA.V) ("Zenabis" or the "Company") is pleased to announce the licensing of Phase 2A at its Zenabis Atholville facility (an additional 3,200kg of cannabis cultivation capacity) and disclose the date of its next operational update: May 21, 2019 (for the month of April 2019 ). This amendment increases licensed operating space from the existing 136,800 square feet at Zenabis Atholville to 174,900 square feet. "Since the creation of Zenabis in January of 2019, we have more than doubled our licensed cultivation capacity from approximately 6,000 kg to 13,400 kg, and we have an additional 9,800 kg of cultivation capacity at Zenabis Atholville submitted and awaiting licensing approval.
Seattle, Washington--(Newsfile Corp. - May 8, 2019) - CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry, announces the publication of an article covering Zenabis Global Inc. (TSXV: ZENA) and its aggressive cannabis production model. With licensed facilities in British Columbia, New Brunswick, and Nova Scotia, near-term and large-scale expansion plans, and supply agreements in place across the country, Zenabis is aiming to take ...
VANCOUVER , May 2, 2019 /CNW/ - Zenabis Global Inc. (ZENA.V) ("Zenabis" or the "Company") announces that it has granted an aggregate of 3,755,511 incentive stock options (each, an "Option") to certain independent directors, officers, employees and consultants of the Company in accordance with the Company's stock option plan on its annual grant cycle. The grant date of these options is May 1, 2019 . Each Option is exercisable into one common share in the capital of the Company (each, a "Share") at a price of $1.91 per Share, being the closing price of the Shares on the TSX Venture Exchange on April 30, 2019 , for a period of three to five years from the date of grant. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
In addition, the Company has filed the financial statements and MD&A for Sun Pharm Investments Ltd. ("Sun Pharm", representing Zenabis' cannabis business prior to the amalgamation with Bevo Agro Inc.) for the year ended December 31, 2018 on SEDAR. Construction is progressing on track at Zenabis Atholville and Zenabis Langley to increase design capacity to at least 131,300 kg by the end of the third quarter of 2019.
Zenabis Partners with Farmako to Supply Mass Produced CBD Isolate in Canada and Medical Cannabis to Germany
"We are very excited to announce the rollout of our new recreational products as they represent a tangible milestone in our product expansion strategy, which will contribute to overall revenue growth in 2019," stated Andrew Grieve , Chief Executive Officer of Zenabis. The Company's new pre-roll products, initially launched in stores in mid-April, are currently being carried in its key markets of New Brunswick and Nova Scotia . Following the receipt of its oil license as announced in news on March 18, 2019 , the Company has begun offering cannabis oil products under its recreational Namaste brand. Initially, the Company will be offering cannabis oil products in 30 mL bottles and will offer additional products such as soft gel capsules and sprays starting in May 2019 .
VANCOUVER , April 22, 2019 /CNW/ - Zenabis Global Inc. (ZENA.V) ("Zenabis" or the "Company") is pleased to announce that it has received conditional approval to graduate its listing from the TSX Venture Exchange (the "TSXV") to the Toronto Stock Exchange (the "TSX"). "Moving to the main board of one of the largest exchanges in the world is a critical milestone for the Company in terms of demonstrating the strength of our business and expanding our investment appeal to a broader and global audience," stated Andrew Grieve , Chief Executive Officer of Zenabis.
VANCOUVER , April 17, 2019 /CNW/ - Zenabis Global Inc. (ZENA.V) ("Zenabis" or the "Company") announces today that it has closed its previously announced fully-marketed, "best efforts" offering (the "Offering") of 12,777,777 units of the Company (each, a "Unit"), which includes the exercise of the agents' over-allotment option in full, at a price of $2.25 per Unit, for aggregate gross proceeds to the Company of approximately $28.75 million , before deducting commissions and expenses of the Offering. Each Unit consists of one common share of the Company (each, a "Common Share") and one common share purchase warrant (each, a "Warrant") to purchase a Common Share at a price of $2.75 for a period of 36 months from today's date. The Warrants have been approved for listing on the TSX Venture Exchange ("TSXV"), under the symbol "ZENA.WT", and trading of the Warrants on the TSXV is expected to commence on April 22, 2019 .
Zenabis Global Inc (ZENA.V) (“Zenabis” or the “Company”) announces that, further to the Company's press release dated April 10, 2019, its fully-marketed, “best efforts” offering (the "Offering") will be of units of the Company (each, a "Unit") at a price of $2.25 per Unit (the "Offering Price"). Each Unit will consist of one common share of the Company (each, a "Common Share") and one common share purchase warrant (each, a "Warrant") to purchase a Common Share at a price of $2.75 for a period of 36 months following the closing date of the Offering.
Zenabis Global Inc (ZENA.V) (“Zenabis” or the “Company”) announces that it has today filed a preliminary prospectus supplement (the “Supplement”) to its short form base shelf prospectus dated April 9, 2019 (the “Shelf Prospectus”) in connection with a fully-marketed, “best efforts” offering of its common shares (the “Offering”). The Supplement was filed with the securities regulatory authorities in each of the provinces of Canada, except Québec. The Offering is expected to raise total gross proceeds of approximately $25.0 million before deducting commissions and estimated expenses of the Offering. The Company intends to use the net proceeds of the Offering to fund the cost of conversion of its facilities to cannabis production and for working capital.
Zenabis Announces Appointment of New Chief Financial Officer and Files Final Base Short Form Prospectus
VANCOUVER , April 1, 2019 /CNW/ - Zenabis Global Inc. ("Zenabis") (ZENA.V) wishes to announce that Donald Fairholm has resigned from its board of directors. The board of directors has initiated the process of finding a new director to fill the vacancy on the board. Note: Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
VANCOUVER , March 27, 2019 /CNW/ - Zenabis Global Inc (ZENA.V) ("Zenabis" or the "Company") is pleased to announce that it has closed its previously announced bought deal private placement of 15,000 unsecured convertible debentures (the "Convertible Debentures") of the Company, at a price of $1,000 per Convertible Debenture (the "Issue Price") for gross proceeds of $15,000,000 (the "Offering"). The Company intends to use the net proceeds of the Offering to fund the cost of conversion of its facilities to cannabis production and for working capital.
AgraFlora Organics International (CSE: AGRA) (OTCPK: PUFXF) is teaming up with Dixie Brands (CSE: DIXI.U) (OTC: DXBRF) (Frankfurt: 0QV) to the manufacture, sale and distribution of cannabis-infused products within legalized markets in the European Union. According to a research report by Prohibition Partners, the cannabis market in the EU may represent as much as €123 […]The post Cannabis Stock News Daily Roundup March 21 appeared first on Market Exclusive.